ARCHIVES

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Change In Method Of Counting Cancer Incidence Results In More Attributed To Work Hazards

October 6, 1978

NCI Bypass Budget Seeks $1 Billion Increase For FY 2011

February 26, 2010

Scientists Defend NCI, Criticize Post Series As Inaccurate

November 20, 1981

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

November 29, 2013

HPV Vaccine Cervarix Active In 100% Of Women In Study

July 27, 2007

Access to mammography needs improvement, IOM National Cancer Policy Board report finds.

June 11, 2004